5th Annual Conference on Psychedelics and Psychedelic Medicine

^5th Annual Conference on Psychedelics & Psychedelic Medicine

Program Agenda

November 14-15, 2025

Day 1 – November 14, 2025

8:30-8:40 AM             Welcome & Introduction

Franklin King, MD

MODULE TOPIC 1: Foundations of Psychedelic Research and Practice

8:40–9:00 AM            History & Pharmacology of Psychedelics Basics

Franklin King, MD

9:00-9:40 AM              Keynote: State of Psychedelic Research in 2025

David Yaden, PhD

9:40-10:00 AM            Panel Discussion

Moderator: Jerrold Rosenbaum, MD

Panelist: David Yaden, PhD

10:00-10:15 AM           Break

MODULE TOPIC 2: The Neuroscience of Psychedelics

10:15-10:35 AM           Advancing the Cognitive Neuroscience of Psychedelics

Sharmin Ghaznavi, MD, PhD

10:35-10:55 AM           Beyond the Trip: Classifying Psychedelic Compounds Through Neural Signatures

Alfred Kaye, MD, PhD

10:55-11:25 AM           Panel Discussion  

  Moderator: Franklin King, MD

  Panelist: Sharmin Ghaznavi, MD, PhD; Alfred Kaye, MD, PhD

MODULE TOPIC 3: Novel Entheogenic Compounds, Natural and Synthetic

11:25-11:45 AM           From Nature to Neuroscience: Novel Plant-Derived Psychedelics & Modeling Human Brain Plasticity with Neurons & Organoids

  Stephen Haggarty, PhD

11:45-12:15 PM           Progress in Novel Entactogens as Therapeutics

                                         Matthew Baggott, PhD

12:15-12:45 PM           Panel Discussion

Moderator: Jerrold Rosenbaum, MD

Panelists: Stephen Haggarty, PhD; Matthew Baggott, PhD; Ben Kelmendi, MD

12:45-12:50 PM             Closing Remarks

Franklin King, MD

Day 2 – November 15, 2025

9:00-9:05 AM              Welcome & Introduction

Franklin King, MD

MODULE TOPIC 4: Clinical Frontiers & Ethical Tensions in Psychedelic Psychiatry

9:05-9:25 AM              Psychedelics & Addictions, from Ketamine to Ibogaine

                                       Joji Suzuki, MD

9:25-9:45 AM              Risks and Potential Harms of Psychedelics

                                    Franklin King, MD 

9:45-10:05 AM            Psilocybin for Anorexia Nervosa

                                        Natalie Gukasyan, MD 

10:05-10:35 AM           Panel Discussion

            Moderator: Franklin King, MD

                                    Panelists: Joji Suzuki, MD; Natalie Gukasyan, MD 

10:35-10:50 AM           Break

MODULE TOPIC 5: Implementation in Healthcare Settings: Insurance, Reimbursement & Medical Populations

10:50-11:10 AM            Navigating Insurance & Reimbursement Pathways in Psychedelic Therapy

 Brian Barnett, MD

11:10-11:30 AM            Ketamine in the General Hospital

Cristina Cusin, MD

11:30-11:50 AM            Psychedelics in Medical Populations: Perspective from a Study of Psilocybin-Assisted Therapy for Irritable Bowel Syndrome

Erin Mauney, MD

11:50-12:20 PM           Panel Discussion

Moderator: Franklin King, MD

Panelists: Brian Barnett, MD; Cristina Cusin, MD; Erin Mauney, MD

12:20-1:20 PM             Lunch Break

MODULE TOPIC 6: Perspectives on Psychedelic-Assisted Therapy

1:20-1:40 PM               On the Differences & Similarities of Working with Patients Using MDMA & Psilocybin

                                         Kelley O’Donnell, MD, PhD

1:40-2:00 PM               Psychedelics in Death & Dying

Yvan Beaussant, MD

2:00-2:20 PM              Psychedelic-Assisted Therapy: Challenges of Capturing the Nuance

Roxanne Sholevar, MD

2:20-2:50 PM              Panel Discussion

            Moderator: Franklin King, MD

Panelists: Kelley O’Donnell, MD, PhD; Yvan Beaussant, MD; Roxanne Sholevar, MD

2:50-3:05 PM              Break

MODULE TOPIC 7: Rules of the Game: Redefining Evidence, Access & Legality in Psychedelic Science

3:05-3:25 PM              Policy & Law in Psychedelics: Navigating Evolving Frameworks

      Allison Hoots, JD

3:25-3:45 PM              Laboratory of the Future? Australia’s prescription psychedelic rollout and other innovations in the Land of Oz

      Paul Liknaitzky, PhD

3:45-4:05 PM              Challenges of Placebo Control in Psychedelic RCTs

Balázs Szigeti, PhD

4:05-4:35 PM              Panel Discussion

            Moderator: Franklin King, MD

Panelists: Allison Hoots, JD; Paul Liknaitzky, PhD; Balázs Szigeti, PhD 

4:35-4:45 PM              Closing Remarks

Franklin King, MD